AptarGroup, Inc. (NYSE:ATR) Receives $122.33 Average PT from Analysts

AptarGroup, Inc. (NYSE:ATR – Get Rating) has earned an average rating of “Moderate Buy” from the eight research firms that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $122.33.

Several equities analysts have weighed in on the company. TheStreet raised AptarGroup from a “c+” rating to a “b-” rating in a research report on Tuesday, January 17th. Robert W. Baird raised their price target on AptarGroup from $105.00 to $115.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 21st. Wells Fargo & Company raised their price target on AptarGroup from $121.00 to $132.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 21st. Deutsche Bank Aktiengesellschaft raised their price target on AptarGroup from $125.00 to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, February 21st. Finally, StockNews.com started coverage on AptarGroup in a report on Thursday. They set a “buy” rating on the stock.

AptarGroup Stock Performance

Shares of ATR stock opened at $110.76 on Thursday. The company has a market cap of $7.24 billion, a price-to-earnings ratio of 30.94, a price-to-earnings-growth ratio of 4.13 and a beta of 0.63. The stock has a 50 day simple moving average of $113.82 and a 200-day simple moving average of $106.75. AptarGroup has a 12-month low of $90.23 and a 12-month high of $122.30. The company has a current ratio of 1.56, a quick ratio of 1.03 and a debt-to-equity ratio of 0.51.

AptarGroup (NYSE:ATR – Get Rating) last released its quarterly earnings data on Friday, February 17th. The industrial products company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.79 by $0.13. AptarGroup had a return on equity of 12.78% and a net margin of 7.20%. The firm had revenue of $795.91 million during the quarter, compared to the consensus estimate of $775.57 million. During the same period last year, the business posted $0.93 EPS. AptarGroup’s quarterly revenue was down 2.2% on a year-over-year basis. On average, equities analysts forecast that AptarGroup will post 3.86 EPS for the current year.

AptarGroup Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 23rd. Shareholders of record on Thursday, February 2nd were paid a dividend of $0.38 per share. This represents a $1.52 dividend on an annualized basis and a dividend yield of 1.37%. The ex-dividend date was Wednesday, February 1st. AptarGroup’s dividend payout ratio is presently 42.46%.

Insiders Place Their Bets

In other news, CFO Robert Kuhn sold 64,560 shares of AptarGroup stock in a transaction dated Tuesday, February 21st. The stock was sold at an average price of $114.04, for a total transaction of $7,362,422.40. Following the sale, the chief financial officer now directly owns 54,044 shares of the company’s stock, valued at $6,163,177.76. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In related news, Director Maritza Gomez Montiel sold 1,500 shares of the business’s stock in a transaction dated Tuesday, February 21st. The stock was sold at an average price of $114.67, for a total value of $172,005.00. Following the completion of the sale, the director now directly owns 4,024 shares of the company’s stock, valued at $461,432.08. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CFO Robert Kuhn sold 64,560 shares of the business’s stock in a transaction dated Tuesday, February 21st. The shares were sold at an average price of $114.04, for a total value of $7,362,422.40. Following the completion of the sale, the chief financial officer now directly owns 54,044 shares of the company’s stock, valued at $6,163,177.76. The disclosure for this sale can be found here. 1.20% of the stock is currently owned by insiders.

Hedge Funds Weigh In On AptarGroup

A number of hedge funds and other institutional investors have recently bought and sold shares of ATR. Raymond James Financial Services Advisors Inc. boosted its stake in AptarGroup by 10.3% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 10,393 shares of the industrial products company’s stock valued at $1,221,000 after acquiring an additional 970 shares during the period. HighTower Advisors LLC boosted its stake in AptarGroup by 6.3% in the first quarter. HighTower Advisors LLC now owns 6,976 shares of the industrial products company’s stock valued at $820,000 after acquiring an additional 416 shares during the period. Great West Life Assurance Co. Can boosted its stake in AptarGroup by 9.1% in the first quarter. Great West Life Assurance Co. Can now owns 37,547 shares of the industrial products company’s stock valued at $4,539,000 after acquiring an additional 3,125 shares during the period. Raymond James Trust N.A. boosted its position in shares of AptarGroup by 7.1% during the first quarter. Raymond James Trust N.A. now owns 4,632 shares of the industrial products company’s stock worth $545,000 after buying an additional 308 shares during the period. Finally, Sei Investments Co. boosted its position in shares of AptarGroup by 0.4% during the first quarter. Sei Investments Co. now owns 122,797 shares of the industrial products company’s stock worth $14,429,000 after buying an additional 484 shares during the period. 89.37% of the stock is currently owned by institutional investors and hedge funds.

About AptarGroup

(Get Rating)

AptarGroup, Inc engages in the design, manufacture, drug delivery, consumer product dispensing, sealing and active packaging solutions, and services for the prescription drug, consumer health care, injectable, active packaging, beauty, personal care, home care, and food and beverages industries. It operates through the following segments: Pharma, Beauty and Home, and Food and Beverage.